title: Gd DTPA. Clinical efficacy.
abstract: Both the diagnostic accuracy and sensitivity of the MRI diagnosis of central nervous system neoplasms appear to be improved by the administration of a paramagnetic contrast agent, Gd DTPA.
authors.affiliation: Department of Radiology, New England Medical Center Hospital, Boston, MA 02111.
authors.forename: V M
authors.initials: VM
authors.lastname: Runge
authors.forename: T F
authors.initials: TF
authors.lastname: Schaible
authors.forename: H A
authors.initials: HA
authors.lastname: Goldstein
authors.forename: M L
authors.initials: ML
authors.lastname: Wood
authors.forename: V M
authors.initials: VM
authors.lastname: Haughton
authors.forename: K R
authors.initials: KR
authors.lastname: Maravilla
authors.forename: M A
authors.initials: MA
authors.lastname: Weinstein
authors.forename: A C
authors.initials: AC
authors.lastname: Price
authors.forename: S M
authors.initials: SM
authors.lastname: Wolpert
authors.forename: D
authors.initials: D
authors.lastname: Kaufman
mesh_terms: D001932:Brain Neoplasms / Q000175:diagnosis*; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008579:Meningioma / Q000175:diagnosis*; D009464:Neuroma, Acoustic / Q000175:diagnosis*; D009942:Organometallic Compounds; D004369:Pentetic Acid
chemical_list: D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA